Team CLOT-LESS mission patch: a red blood vessel containing a fibrin clot, crossing a deep navy roundel marked University of British Columbia and CLOT-LESS, with a white maple leaf and stars.

CAN-RGX 2025–26 · Canadian Space Agency

An Analysis of Thrombolysis Kinetics in Microgravity

Team CLOT-LESS built and flew an experimental platform to study thrombolysis and other hematologic research questions in zero gravity, and presented the first results at IAC 2026.

Two CLOT-LESS team members on stage at the 77th International Astronautical Congress in Antalya, beside the title slide of their talk.

Latest · October 2026

Presented at the International Astronautical Congress

Team CLOT-LESS presented its parabolic flight results at the 77th IAC in Antalya, Türkiye — the first look at how a clot-dissolving drug behaves in microgravity.

With each repeat infusion, clots treated with tenecteplase became easier to push fluid through, potentially signalling that they were breaking down, while the saline controls barely changed.

Preliminary — with our limited number of samples, statistical significance cannot be established.

What the flight showed →

CLOT-LESS team members in flight suits seated beside the experiment laptop inside the aircraft.

Our flight campaign

In the news · CBC · 10 September 2026 CBC's Stu Mills flew along with the student teams on the National Research Council's Falcon 20 during the campaign. Watch on CBC ↗

Photos and videos →

  • 20

    Parabolas

    Across two flight days

  • 22 s

    Microgravity window

    Per parabola, measured

  • 8

    Microfluidic channels

    4 drug, 4 saline control

  • 13.3 kg

    Payload mass

    70.5% margin

Project goals

  • Develop a testable platform for zero-g research

    Develop an experimental platform for testing thrombolysis and other hematologic research questions in zero gravity, with ground testing to support repeatable experiments.

  • Quantify microgravity effects on thrombolysis

    Measure the differential pressure change across a clot-containing microchannel during tenecteplase perfusion, in microgravity and at 1 g, over matched twenty-second analysis windows.

  • Validate system reliability

    Confirm that the integrated fluidic, sensing and logging system behaves consistently across repeated parabolas — to support repeatable hematologic experiments in reduced gravity.

  • Deliver scholarly and educational impact

    Translate the findings into peer-reviewed output and into classrooms — because a result that stays inside the team does not advance the field or the next generation working in it.

Read the full mission brief →

The team